Dye injection to help see cancer during belly surgery
Part of Cancer, Digestive system clinical trials.
This study tests a special dye, called pafolacianine, that is injected before surgery to help surgeons see hidden cancer spots in the belly during the operation. The goal is to see if using this dye improves how completely the cancer is removed in people with gastrointestinal cancer that has spread to the belly lining.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have gastrointestinal cancer (adenocarcinoma type) that has spread to the lining of your belly, and you are scheduled for surgery to remove it
- You are not pregnant and, if you could become pregnant, you agree to use birth control during the study and for 30 days after
- You have not had a severe allergic reaction to fluorescent light, folic acid, or the study drug CYTALUX
- Your kidney and liver function are within safe limits, and you have no major heart problems on an ECG
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called pafolacianine (CYTALUX) that makes cancer cells glow during surgery. It may help doctors see and remove more cancer from the stomach, esophagus, or appendix. You take the drug before surgery, and a special camera shows the glowing cancer.
This trial tests a dye called abenacianine (VGT-309) that may help surgeons see cancer more clearly during lung surgery. It looks at whether the dye is safe and effective for identifying cancer in people having surgery to remove a lung lesion or mass.
This trial tests a dye called Cytalux that helps surgeons see cancer during surgery. You get the dye before surgery, and it makes cancer cells glow under a special light. This could help doctors remove more cancer.
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
This trial tests a dye called Cytalux (pafolacianine) to help surgeons see cancer during lung or ovarian cancer surgery. If you are scheduled for surgery to remove lung cancer or to debulk ovarian cancer, you may be eligible.
This study tests a special imaging drug called pafolacianine (Cytalux) that helps doctors see tumors more clearly during surgery. It is for children and teens who have a solid tumor in the body and are already scheduled for tumor removal or biopsy.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.